Welcome to our dedicated news page for JUSTERA HEALTH (Ticker: SCRSF), a resource for investors and traders seeking the latest updates and insights on JUSTERA HEALTH.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JUSTERA HEALTH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JUSTERA HEALTH's position in the market.
Justera Health (OTC Pink: SCRSF) announces a delay in filing its audited annual financial statements, which may lead to a failure-to-file cease trade order by the OSC. The Company is working to finalize the filings promptly to resume normal trading conditions.
Justera Health (CSE: VTAL) (OTC Pink: SCRSF) has announced the resignation of Tyler Burpee from its board for personal reasons, effective April 24, 2024. The company expresses gratitude for Mr. Burpee's service and contributions, with CEO Young Cho Lee emphasizing the commitment to continuing strategic objectives.
